Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
contrast agent
gadolinium-based contrast agent |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
V08CA04
|
| gptkbp:brand |
ProHance
|
| gptkbp:CASNumber |
120066-54-8
|
| gptkbp:containsElement |
gptkb:gadolinium
|
| gptkbp:developer |
Bracco Diagnostics
|
| gptkbp:eliminationHalfLife |
1.5 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C17H29GdN4O7
|
| https://www.w3.org/2000/01/rdf-schema#label |
gadoteridol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:riskFactor |
gptkb:nephrogenic_systemic_fibrosis
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:usedFor |
magnetic resonance imaging
|
| gptkbp:bfsParent |
gptkb:gadolinium-based_contrast_agents
|
| gptkbp:bfsLayer |
7
|